Newlink Genetics reported $83K in Ordinary Share Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agenus AGEN:US $ 2.67M 0.1M
Bristol Myers Squibb BMY:US $ 292M 0M
Capricor Therapeutics CAPR:US $ 0.02M 0M
Celldex Therapeutics CLDX:US $ 0.05M 0M
Eli Lilly And LLY:US $ 594.1M 2.2M
Idera Pharmaceuticals IDRA:US $ 0.05M 0M
Intrexon XON:US $ 0M 0M
Merk MRK:US $ 1788M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Newlink Genetics NLNK:US $ 0.08M 0M
Prothena PRTA:US $ 0.47M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Vascular Biogenics VBLT:US 173K 1.6M
YTE INCY:US $ 0.22M 0M